(function(){var loadHandler=window['sl_{8D51A9B2-A6B7-4FD6-87EA-EEA030EAF4DB}'];loadHandler&&loadHandler(9, '<div id="spr0_420848d3"><div id="spr1_420848d3" class="kern slide"><img id="img0_420848d3" src="data:image/png;base64,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" width="960px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_420848d3" class="kern slide"><div id="spr3_420848d3" style="left:66px;top:-7.25px;"><div style="width:0px;"><span id="txt0_420848d3" data-width="667.777344" style="left:80.42px;top:18.23px;">Management of Pulmonary Embolism</span></div></div><div id="spr4_420848d3" style="left:30.6px;top:97.125px;"><div style="width:0px;"><span id="txt1_420848d3" data-width="770.053711" style="left:7.2px;top:-5.56px;">1)  Mary has no active cancer, has normal kidney function and is not pregnant. What</span></div><div style="width:0px;"><span id="txt2_420848d3" data-width="335.016602" style="left:7.2px;top:12.92px;">treatment should we start for Mary?</span></div></div><div id="spr5_420848d3" style="left:30.6px;top:97.125px;"><div style="width:0px;"><span id="txt3_420848d3" class="nokern relpos" style="left:43.2px;top:40.757px;"></span><span id="txt4_420848d3" class="relpos" data-width="741.677246" style="left:46.106px;top:37.649px;"> Oral factor Xa Inhibitors (e.g. apxiban, rivoroxaban) can be used for Mary if there are no contra-</span></div><div style="width:0px;"><span id="txt5_420848d3" data-width="88.774902" style="left:61.2px;top:53.609px;">indications.</span></div></div><div id="spr6_420848d3" style="left:30.6px;top:97.125px;"><div style="width:0px;"><span id="txt6_420848d3" class="nokern relpos" style="left:43.2px;top:77.677px;"></span><span id="txt7_420848d3" class="relpos" data-width="778.229980" style="left:46.106px;top:74.569px;"> They are preferred to dabigatran and warfarin as they do not require parenteral anti-coagulation for</span></div><div style="width:0px;"><span id="txt8_420848d3" data-width="177.345703" style="left:61.2px;top:90.529px;">initiation of treatment.</span></div></div><div id="spr7_420848d3" style="left:30.6px;top:97.125px;"><div style="width:0px;"><span id="txt9_420848d3" class="nokern relpos" style="left:43.2px;top:114.597px;"></span><span id="txt10_420848d3" class="relpos" data-width="756.752930" style="left:44.269px;top:111.489px;">Mary is hence started on Apxiban 10 mg orally, twice daily for 7 days. This is then reduced to 5 mg</span></div><div style="width:0px;"><span id="txt11_420848d3" data-width="87.290527" style="left:61.2px;top:127.449px;">twice daily.</span></div></div><div id="spr8_420848d3" style="left:30.6px;top:97.125px;"><div style="width:0px;"><span id="txt12_420848d3" data-width="506.032227" style="left:7.2px;top:180.64px;">2) How long should Mary take the anti-coagulation for?</span></div></div><div id="spr9_420848d3" style="left:30.6px;top:97.125px;"><div style="width:0px;"><span id="txt13_420848d3" class="nokern relpos" style="left:43.2px;top:208.477px;"></span><span id="txt14_420848d3" class="relpos" data-width="32.461426" style="left:46.106px;top:205.369px;">In a </span><span id="txt15_420848d3" class="relpos" data-width="86.910156" style="left:46.101px;top:205.369px;">PROVOKED</span><span id="txt16_420848d3" class="relpos" data-width="176.631348" style="left:46.096px;top:205.369px;">  Pulmonary Embolism </span><span id="txt17_420848d3" class="relpos" style="left:46.091px;top:208.477px;"></span><span id="txt18_420848d3" class="relpos" style="left:46.086px;top:205.369px;"> </span><span id="txt19_420848d3" class="relpos" data-width="310.596191" style="left:46.081px;top:205.369px;">treat with anti-coagulation for 3 months</span></div></div><div id="spr10_420848d3" style="left:30.6px;top:97.125px;"><div style="width:0px;"><span id="txt20_420848d3" class="nokern relpos" style="left:43.2px;top:229.437px;"></span><span id="txt21_420848d3" class="relpos" data-width="762.031738" style="left:46.106px;top:226.329px;">Mary has one major risk factor- oestrogen therapy. Mary stops her contraceptive pill and discusses</span></div><div style="width:0px;"><span id="txt22_420848d3" data-width="487.440918" style="left:61.2px;top:242.289px;">with her General practitioner alternate forms of contraception.</span></div></div><div id="spr11_420848d3" style="left:30.6px;top:97.125px;"><div style="width:0px;"><span id="txt23_420848d3" class="nokern relpos" style="left:43.2px;top:266.357px;"></span><span id="txt24_420848d3" class="relpos" data-width="785.865234" style="left:46.106px;top:263.249px;">Other major provoking factors include: major surgery, hospitalisation with immobilisation, pregnancy.</span></div></div><div id="spr12_420848d3" style="left:30.6px;top:97.125px;"><div style="width:0px;"><span id="txt25_420848d3" class="nokern relpos" style="left:43.2px;top:287.317px;"></span><span id="txt26_420848d3" class="relpos" data-width="102.774414" style="left:46.106px;top:284.209px;">If the PE was </span><span id="txt27_420848d3" class="relpos" data-width="138.881836" style="left:46.101px;top:284.209px;">UNPROVOKED –&gt; </span><span id="txt28_420848d3" class="relpos" data-width="355.943848" style="left:46.096px;top:284.209px;">Mary would require life-long anti-coagulation.</span></div></div><div id="spr13_420848d3" style="left:30.6px;top:97.125px;"><div style="width:0px;"><span id="txt29_420848d3" data-width="672.998047" style="left:7.2px;top:337.4px;">3) What supportive management can be used alongside anti-coagulation?</span></div></div><div id="spr14_420848d3" style="left:30.6px;top:97.125px;"><div style="width:0px;"><span id="txt30_420848d3" class="nokern relpos" style="left:43.2px;top:365.237px;"></span><span id="txt31_420848d3" class="relpos" data-width="145.088379" style="left:46.106px;top:362.129px;">Pain management.</span></div></div><div id="spr15_420848d3" style="left:30.6px;top:97.125px;"><div style="width:0px;"><span id="txt32_420848d3" class="nokern relpos" style="left:43.2px;top:386.197px;"></span><span id="txt33_420848d3" class="relpos" data-width="277.559570" style="left:46.106px;top:383.089px;">Oxygen -if saturations are dropping.</span></div></div></div></div>');})();